FR2206943A1 - - Google Patents

Info

Publication number
FR2206943A1
FR2206943A1 FR7340923A FR7340923A FR2206943A1 FR 2206943 A1 FR2206943 A1 FR 2206943A1 FR 7340923 A FR7340923 A FR 7340923A FR 7340923 A FR7340923 A FR 7340923A FR 2206943 A1 FR2206943 A1 FR 2206943A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7340923A
Other versions
FR2206943B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2206943A1 publication Critical patent/FR2206943A1/fr
Application granted granted Critical
Publication of FR2206943B1 publication Critical patent/FR2206943B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
FR7340923A 1972-11-18 1973-11-16 Expired FR2206943B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11602172A JPS4971127A (fr) 1972-11-18 1972-11-18

Publications (2)

Publication Number Publication Date
FR2206943A1 true FR2206943A1 (fr) 1974-06-14
FR2206943B1 FR2206943B1 (fr) 1977-09-02

Family

ID=14676810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7340923A Expired FR2206943B1 (fr) 1972-11-18 1973-11-16

Country Status (6)

Country Link
JP (1) JPS4971127A (fr)
BE (1) BE807312A (fr)
CA (1) CA1036072A (fr)
DE (1) DE2357389A1 (fr)
FR (1) FR2206943B1 (fr)
GB (1) GB1432784A (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381521A1 (fr) * 1977-02-24 1978-09-22 Kali Chemie Pharma Gmbh Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
EP0005121A2 (fr) * 1978-04-25 1979-10-31 Pharmaceutical Licences Company Ltd. Procédé de stabilisation de 4-methyl-5-(2'chlorethyl)-thiazol
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
FR2500302A1 (fr) * 1981-02-25 1982-08-27 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
EP0108295A1 (fr) * 1982-10-15 1984-05-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Forme de dosage orale
FR2569561A1 (fr) * 1984-08-30 1986-03-07 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
EP0302370A1 (fr) * 1987-08-07 1989-02-08 Abbott Laboratories Formulations d'erythromycine pour l'administration orale

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4230702A (en) * 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
JPS60153758A (ja) * 1984-01-23 1985-08-13 Kao Corp 油脂組成物
JP2537658B2 (ja) * 1987-04-13 1996-09-25 小野薬品工業株式会社 エステル類またはアミド類を有効成分として含有する新規な製剤
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
JP5666760B2 (ja) * 2005-03-31 2015-02-12 サントリーホールディングス株式会社 リグナン類化合物含有組成物
TWI406867B (zh) 2005-09-30 2013-09-01 Suntory Holdings Ltd And a method for producing a high content of episesamin
EP2002832A4 (fr) * 2006-03-31 2009-11-11 Suntory Holdings Ltd Composition contenant un compose lignane

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (fr) *

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE567598A (fr) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381521A1 (fr) * 1977-02-24 1978-09-22 Kali Chemie Pharma Gmbh Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
EP0005121A2 (fr) * 1978-04-25 1979-10-31 Pharmaceutical Licences Company Ltd. Procédé de stabilisation de 4-methyl-5-(2'chlorethyl)-thiazol
EP0005121A3 (en) * 1978-04-25 1979-11-28 Pharmaceutical Licences Company Ltd. Stabilisation process
US4247702A (en) * 1978-04-25 1981-01-27 Pharmaceutical Licences Company Ltd. Method of stabilizing 4-methyl-5-(2'chloroethyl)-thiazol
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
FR2500302A1 (fr) * 1981-02-25 1982-08-27 Negma Laboratoires Nouvelles compositions pharmaceutiques d'indometacine
EP0108295A1 (fr) * 1982-10-15 1984-05-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Forme de dosage orale
FR2569561A1 (fr) * 1984-08-30 1986-03-07 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
EP0302370A1 (fr) * 1987-08-07 1989-02-08 Abbott Laboratories Formulations d'erythromycine pour l'administration orale

Also Published As

Publication number Publication date
AU6254373A (en) 1975-05-15
BE807312A (fr) 1974-03-01
CA1036072A (fr) 1978-08-08
GB1432784A (en) 1976-04-22
DE2357389A1 (de) 1974-05-22
FR2206943B1 (fr) 1977-09-02
JPS4971127A (fr) 1974-07-10

Similar Documents

Publication Publication Date Title
FR2206943A1 (fr)
CS168466B2 (fr)
CS163805B1 (fr)
CS166665B2 (fr)
CS175353B2 (fr)
CS169955B1 (fr)
CS172471B1 (fr)
CS169948B1 (fr)
CS157938B1 (fr)
CS163900B1 (fr)
CS159691B1 (fr)
CS163487B1 (fr)
CS163435B1 (fr)
CS159707B2 (fr)
CS159508B1 (fr)
CS159125B1 (fr)
CS159110B1 (fr)
CS159006B1 (fr)
CS159005B1 (fr)
CH545744A (fr)
CH569667A5 (fr)
CH579803A5 (fr)
CH580066A5 (fr)
CH584057A5 (fr)
CH587367A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse